CNBC August 10, 2023
Key Points
– Medicare, in the coming weeks, will announce the 10 drugs that will be subject to price negotiations this year.
– It is the first time the program for seniors has directly negotiated prices with the pharmaceutical industry.
– It is still unclear which 10 drugs Medicare will select, but several pharmaceutical companies have already revealed in court filings that they expect four of their blockbuster medications to be targeted.
– The pharmaceutical industry has filed a torrent of lawsuits to block the negotiations, arguing that the program is an unconstitutional seizure of their property.
Medicare is poised to directly negotiate drug prices with the pharmaceutical industry this fall for the first time in the program’s nearly six-decade...